Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-19-045096
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-08 16:19:01
Reporting Period:
2019-08-06
Accepted Time:
2019-08-08 16:19:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578696 David Davidson C/o Bluebird Bio, Inc.
60 Binney Street
Cambridge MA 02142
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-06 5,060 $50.51 36,676 No 4 M Direct
Common Stock Disposition 2019-08-06 2,960 $115.25 33,716 No 4 S Direct
Common Stock Disposition 2019-08-06 800 $116.11 32,916 No 4 S Direct
Common Stock Disposition 2019-08-06 900 $117.77 32,016 No 4 S Direct
Common Stock Disposition 2019-08-06 400 $118.44 31,616 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-08-06 5,060 $0.00 5,060 $50.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,685 2026-03-01 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2019.
  2. The range in prices for the transaction reported on this line was $114.58 to $115.50. The average weighted price was $115.2473. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The range in prices for the transaction reported on this line was $115.81 to $116.80. The average weighted price was $116.107. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The range in prices for the transaction reported on this line was $117.27 to $118.18. The average weighted price was $117.7722. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017 and in 36 equal monthly installments thereafter.